Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Mutualfunds logo

BHSRX BlackRock Health Sciences Opps R

  • Fund
  • BHSRX
  • Price as of: Nov 17, 2017
  • $53.46
  • - $0.17
  • - 0.32%
  • Category
  • Health & Biotech Equities

BHSRX - Profile

Vitals

  • YTD Return 22.0%
  • 3 Yr Annualized Return 9.2%
  • 5 Yr Annualized Return 19.1%
  • Net Assets $6 B
  • Holdings in Top 10 35.4%

52 WEEK LOW AND HIGH

$53.46
$43.25
$54.39

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.51%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 50.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$100

IRA

$100

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 22.0%
  • 3 Yr Annualized Total Return 9.2%
  • 5 Yr Annualized Total Return 19.1%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.35%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name BlackRock
  • Inception Date Sep 12, 2011
  • Shares Outstanding N/A
  • Share Class Retirement
  • Currency USD
  • Domiciled Country United States
  • Manager Erin Xie

Fund Description

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.

BHSRX - Performance

Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 22.0% -14.9% 36.8% 33.04% 2
1 Yr 24.8% -14.8% 43.9% 21.62% 2
3 Yr 9.2% * -7.5% 18.5% 36.11% 2
5 Yr 19.1% * 9.3% 22.0% 24.27% 2
10 Yr 12.3% * 6.1% 17.5% 32.04% 2

* Annualized


Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -8.6% -29.8% 2.6% 20.00% 2
2015 -2.1% -20.4% 14.5% 48.18% 3
2014 20.2% -5.8% 33.7% 30.91% 2
2013 30.3% -2.6% 65.2% 69.72% 4
2012 10.1% -5.3% 36.5% 66.02% 4

Total Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 22.0% -14.9% 36.8% 33.33% 2
1 Yr 24.8% -18.3% 43.9% 20.00% 1
3 Yr 9.2% * -14.2% 18.5% 33.33% 2
5 Yr 19.1% * 9.1% 22.0% 20.39% 1
10 Yr 12.3% * 6.1% 17.2% 29.13% 2

* Annualized


Total Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -8.6% -25.1% 6.3% 22.02% 2
2015 -2.1% -16.6% 39.1% 83.49% 5
2014 31.0% -5.8% 100.0% 61.47% 4
2013 56.6% -5.1% 398.7% 82.41% 5
2012 27.3% -2.6% 475.8% 80.00% 4

NAV & Total Return History

BHSRX - Holdings

Filings data as of: Sep 30, 2017

Concentration Analysis

BHSRX Category Low Category High BHSRX % Rank Quintile
Net Assets 6 B 18.6 M 47 B 6.25% 1
Number of Holdings 111 31 361 8.93% 1
Net Assets in Top 10 2.14 B 11 M 20.2 B 6.25% 1
Weighting of Top 10 35.4% 19.8% 71.2% 34.82% 4

Top 10 Holdings

  1. UnitedHealth Group Inc 8.05%
  2. Medtronic PLC 3.80%
  3. Boston Scientific Corp 3.13%
  4. Amgen Inc 3.30%
  5. Celgene Corp 3.39%
  6. Humana Inc 2.86%
  7. Stryker Corp 3.08%
  8. Cigna Corp 2.59%
  9. Abbott Laboratories 2.66%
  10. Baxter International Inc 2.54%

Asset Allocation

Weighting Category Low Category High BHSRX % Rank Quintile
Stocks
95.67% 91.83% 99.98% 37.50% 5
Cash
2.32% -0.04% 5.66% 13.39% 2
Other
1.26% -5.64% 5.15% 2.68% 1
Preferred Stocks
0.75% 0.00% 4.16% 13.39% 2
Convertible Bonds
0.00% 0.00% 0.46% 2.68% 5
Bonds
0.00% 0.00% 4.69% 7.14% 5

Stock Sector Breakdown

Weighting Category Low Category High BHSRX % Rank Quintile
Healthcare
94.63% 11.15% 99.98% 23.21% 3
Technology
0.59% 0.00% 65.49% 27.68% 4
Consumer Cyclical
0.45% 0.00% 7.41% 2.68% 1
Utilities
0.00% 0.00% 0.95% 1.79% 5
Real Estate
0.00% 0.00% 1.52% 1.79% 5
Industrials
0.00% 0.00% 8.26% 8.04% 5
Financial Services
0.00% 0.00% 2.90% 6.25% 5
Energy
0.00% 0.00% 0.09% 1.79% 5
Communication Services
0.00% 0.00% 0.00% 0.89% 5
Consumer Defense
0.00% 0.00% 1.65% 14.29% 5
Basic Materials
0.00% 0.00% 2.25% 6.25% 5

Stock Geographic Breakdown

Weighting Category Low Category High BHSRX % Rank Quintile
US
88.86% 60.72% 99.98% 18.75% 2
Non US
6.81% 0.00% 34.72% 25.89% 4

BHSRX - Expenses

Operational Fees

BHSRX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.51% 0.10% 4.31% 30.36% 3
Management Fee 0.68% 0.09% 1.25% 10.71% 3
12b-1 Fee 0.50% 0.00% 1.00% 5.06% 3
Administrative Fee 0.06% 0.01% 0.40% 12.31% 2

Sales Fees

BHSRX Fees (% of AUM) Category Low Category High BHSRX Rank Quintile
Front Load N/A 2.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

BHSRX Fees (% of AUM) Category Low Category High BHSRX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BHSRX Fees (% of AUM) Category Low Category High BHSRX Rank Quintile
Turnover 50.00% 0.00% 699.00% 13.39% 4

BHSRX - Distributions

Dividend Yield Analysis

BHSRX Category Low Category High BHSRX % Rank Quintile
Dividend Yield 0.0% 0.01% 0.94% 79.17% 5

Dividend Distribution Analysis

BHSRX Category Low Category High Category Mode
Dividend Distribution Frequency Quarterly Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

BHSRX Category Low Category High BHSRX % Rank Quintile
Net Income Ratio -0.35% -2.22% 1.46% 37.50% 3

Capital Gain Distribution Analysis

BHSRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

BHSRX - Managers

Erin Xie

Manager

Start Date

Jul 31, 2003

Tenure

14.26

Tenure Rank

7.8%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.


Tenure Analysis

Category Low

0.3

Category High

20.1

Category Average

9.06

Category Mode

0.7